No Prescription |
 |
 | ||
|
Nuelin SR Theo Dur |
|
| ||
No Prescription » Prescription Drugs 12 » Nuelin SR Theo Dur Theophylline is used to prevent and treat wheezing shortness of breath and difficulty breathing caused by asthma chronic bronchitis emphysema and other lung diseases. It relaxes and opens air passages in the lungs making it easier to breathe.Theophylline comes as a tablet capsule solution and syrup to take by mouth. It usually is taken every 6 8 12 or 24 hours. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take theophylline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Take this medication with a full glass of water on an empty stomach at least 1 hour before or 2 hours after a meal. Do not chew or crush the extended-release (long-acting) tablets; swallow them whole. Extended-release capsules (e.g. Theo-Dur Sprinkles) may be swallowed whole or opened and the contents mixed with soft food and swallowed without chewing.Theophylline controls symptoms of asthma and other lung diseases but does not cure them. Continue to take theophylline even if you feel well. Do not stop taking theophylline without talking to your doctor.Theophylline is sometimes used to treat breathing problems in premature infants. Buy Nuelin SR Theo Dur and other Prescription Drugs 12 products online at Medstore. 144
About Nuelin SR Theo Dur: Product Type: Prescription Drugs 12 Nuelin SR ( Theo-Dur Bronkodyl Slo-phyllin Theolair Elixophyllin Theo-24 Theochron Uniphyl Generic Theophylline ) Nuelin SR (Theo-Dur Bronkodyl Slo-phyllin Theolair Elixophyllin Theo-24 Theochron Uniphyl Generic Theophylline) Theo-Dur Bronkodyl Slo-phyllin Theolair Elixophyllin Theo-24 Theochron Uniphyl Generic Theophylline 300mg 100 tabs Theo-Dur Bronkodyl Slo-phyllin Theolair Elixophyllin Theo-24 Theochron Uniphyl Generic Theophylline Nuelin SR
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
